ATE297760T1 - Pharmazeutische zusammensetzungen enthaltend terbinafin - Google Patents

Pharmazeutische zusammensetzungen enthaltend terbinafin

Info

Publication number
ATE297760T1
ATE297760T1 AT01902337T AT01902337T ATE297760T1 AT E297760 T1 ATE297760 T1 AT E297760T1 AT 01902337 T AT01902337 T AT 01902337T AT 01902337 T AT01902337 T AT 01902337T AT E297760 T1 ATE297760 T1 AT E297760T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
terbinafin
containing terbinafin
terbinafine
Prior art date
Application number
AT01902337T
Other languages
German (de)
English (en)
Inventor
Stefan Hirsch
Dieter Becker
Patrice Guitard
Andreas Carl Eugster
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE297760T1 publication Critical patent/ATE297760T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01902337T 2000-01-20 2001-01-18 Pharmazeutische zusammensetzungen enthaltend terbinafin ATE297760T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0001315.1A GB0001315D0 (en) 2000-01-20 2000-01-20 Organic compounds
PCT/EP2001/000562 WO2001052895A1 (en) 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine

Publications (1)

Publication Number Publication Date
ATE297760T1 true ATE297760T1 (de) 2005-07-15

Family

ID=9884039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902337T ATE297760T1 (de) 2000-01-20 2001-01-18 Pharmazeutische zusammensetzungen enthaltend terbinafin

Country Status (10)

Country Link
US (2) US20030017200A1 (enExample)
EP (1) EP1259261B1 (enExample)
JP (1) JP2003520252A (enExample)
AT (1) ATE297760T1 (enExample)
AU (1) AU2001230195A1 (enExample)
DE (1) DE60111503T2 (enExample)
ES (1) ES2241777T3 (enExample)
GB (1) GB0001315D0 (enExample)
PT (1) PT1259261E (enExample)
WO (1) WO2001052895A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
ATE346590T1 (de) * 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
RU2214237C1 (ru) * 2002-04-24 2003-10-20 Закрытое акционерное общество "Брынцалов-А" Противогрибковое средство "брамизил"
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
CA3063288A1 (en) 2017-05-12 2018-11-15 Mavalon Therapeutics Limited Substituted heterocyclic compounds as allosteric modulators of group ii metabotropic glutamate receptors
CN110200929A (zh) * 2018-12-14 2019-09-06 悦康药业集团上海制药有限公司 一种含有盐酸特比萘芬的口服片及其制备方法
CN109674757A (zh) * 2019-02-22 2019-04-26 济南康和医药科技有限公司 一种盐酸特比萘芬组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
US4894592A (en) * 1988-05-23 1990-01-16 Fusion Systems Corporation Electrodeless lamp energized by microwave energy
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5661170A (en) * 1994-03-21 1997-08-26 Woodward Laboratories, Inc. Antimicrobial compositions and methods for using the same
GB9509631D0 (en) * 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
GB9513750D0 (en) * 1995-07-06 1995-09-06 Sandoz Ltd Use of allylamines
RU2184570C2 (ru) * 1997-09-30 2002-07-10 Дайити Фармасьютикал Ко., Лтд. Препараты для орального введения
JP2000086503A (ja) * 1998-09-07 2000-03-28 Pola Chem Ind Inc 錠剤医薬組成物

Also Published As

Publication number Publication date
US20030017200A1 (en) 2003-01-23
EP1259261A1 (en) 2002-11-27
JP2003520252A (ja) 2003-07-02
ES2241777T3 (es) 2005-11-01
DE60111503D1 (de) 2005-07-21
US20100197804A1 (en) 2010-08-05
DE60111503T2 (de) 2006-05-18
WO2001052895A1 (en) 2001-07-26
PT1259261E (pt) 2005-10-31
AU2001230195A1 (en) 2001-07-31
EP1259261B1 (en) 2005-06-15
GB0001315D0 (en) 2000-03-08

Similar Documents

Publication Publication Date Title
AP2005003318A0 (en) Pharmaceutical compositions comprising a basic respectively acidic drug coumpound, a surfactant and a physiologically tolerable watersoluble acid respectively base.
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
NO20074807L (no) Fast farmasoytisk doseringsformulering
ITTO20010005A1 (it) Formulazione farmaceutica.
EE05475B1 (et) Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
ATE355271T1 (de) Pharmazeutische zusammensetzung
ATE513541T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung von calcitonin
EE200300228A (et) Tiotroopium- ja salmeteroolsooladel põhinevad ravimkompositsioonid
ATE259658T1 (de) Anästhetische zubereitung enthaltend einen nmda- antagonisten und einen alpha-2 adrenergen agonisten
ES2157881T3 (es) Metanosulfonato de paroxetina.
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
BG108516A (en) Pharmaceutical formulation
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
DE60210139D1 (de) Pharmazeutische zusammensetzungen enthaltend tegaserod
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
ATE366128T1 (de) Pharmazeutische zusammensetzung
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
SE0001916D0 (sv) Novel formulation
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
DE10291905D2 (de) Pharmazeutische Zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1259261

Country of ref document: EP

REN Ceased due to non-payment of the annual fee